| Mary B. Atkins, F.N.P., retired Family Nurse Practitioner, Elkton, VA. | |
 Sunil S. Badve, M.D.,
Associate Professor, Director of Immunohistochemistry Clarian Pathology Laboratory, Department of Pathology and Laboratory Medicine, Indiana University Hospital, Indianapolis, IN. |
|
 John H. Barton, Jr., M.D.,
Medical Oncologist, Tennessee Oncology, Murfreesboro , TN.Learn more about Dr. Barton. |
|
 Olufunmilayo F. Olopade, M.D. FACP,
Professor of Medicine and Human Genetics, and Director, Cancer Risk Clinic, The University of Chicago Medical Center, Chicago, IL.
|
|
 George W. Sledge, Jr., M.D.,
Professor of Medicine, Medical Oncologist, Hematology/Oncology, Indiana Cancer Pavilion, Indianapolis, IN, and ASCO past President 2010-2011. Mid-January 2013, Dr. George W. Sledge will be the new chief of oncology in Stanford’s Department of Medicine. |
|
 Patricia S. Steeg, Ph.D.,
Chief of the Women’s Cancers Section, at the Center for Cancer Research, National Cancer Institute in Bethesda, MD and Director of the Molecular Therapeutics Program, Center for Cancer Research, NCI. |
|
 Danny R. Welch, Ph.D.,
Professor and Chair of Cancer Biology, University of Kansas’ KU Medical Center.Learn more about Dr. Welch. |
The Inflammatory Breast Cancer Research Foundation thanks Medical Advisory Board Member Emeritus, Douglas J. Schwartzentruber, M.D., FACS, associate director of clinical affairs at the Indiana University Melvin and Bren Simon Cancer Center for his years of service.
